Form 4 for LUNG Pulmonx Corp
Accepted 2022-12-05 00:00:00 ET · period of report 2022-12-01 · accession 0001209191-22-059855 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-12-05 | 2022-12-01 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $5.93 | -3,631 | 1.04M | -0.3% | -$21.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-01 | S | D | 2,195 | $5.93 | 1,034,313 | D | — | — | |
| 2 | Common | Common Stock | 2022-12-01 | S | D | 1,436 | $5.93 | 1,036,508 | D | — | — |